Free Trial
NASDAQ:FMED

Fidelity Disruptive Medicine ETF (FMED) Price, Holdings, & News

$23.54 -0.13 (-0.53%)
Closing price 08/1/2025 03:55 PM Eastern
Extended Trading
$23.56 +0.01 (+0.04%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Fidelity Disruptive Medicine ETF (NASDAQ:FMED)

Key Stats

Today's Range
$23.35
$23.62
50-Day Range
$23.01
$24.22
52-Week Range
$20.69
$26.79
Volume
3,590 shs
Average Volume
5,718 shs
Market Capitalization
$51.80 million
Assets Under Management
$52.42 million
Dividend Yield
0.47%
Net Expense Ratio
0.51%
Aggregate Rating
Moderate Buy

ETF Overview

Fidelity Disruptive Medicine ETF Expenses

TypeFMEDTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.57%0.56%0.54%0.53%
Other Expenses0.01%0.57%0.56%0.52%0.56%
Total Expense0.51%0.74%0.76%0.73%0.73%
Fee Waiver0.00%-0.76%-0.66%-0.50%-0.63%
Net Expense0.51%0.60%0.63%0.63%0.60%
Receive FMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fidelity Disruptive Medicine ETF and its competitors with MarketBeat's FREE daily newsletter.

FMED ETF News Headlines

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Update
Fidelity Disruptive Medicine ETF declares $0.112 dividend
See More Headlines

FMED ETF - Frequently Asked Questions

Fidelity Disruptive Medicine ETF's stock was trading at $24.66 at the beginning of the year. Since then, FMED shares have decreased by 4.5% and is now trading at $23.5450.

Fidelity Disruptive Medicine ETF's top institutional shareholders include Wealth Enhancement Advisory Services LLC (31.31%).

Shares of FMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

Issuer
Fidelity
Fund Name
Fidelity Disruptive Medicine ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:FMED
Inception Date
6/12/2023
Fund Manager
Niamh Brodie-Machura, Camille Carlstrom, Tim Codrington,Charlie Hebard,Michael Kim, Christopher Lee,William Shanley
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
70

Fund Statistics

Assets Under Management
$52.42 million
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
Fidelity Management & Research Company, LLC
Advisor
Fidelity Management & Research Company, LLC
Custodian
State Street Bank and Trust Company
Distributor
Fidelity Distributors Company LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
900 shs

Miscellaneous

Beta
1.01
Creation Fee
$200.00
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Top 10 FMED Holdings

FMED Sector Exposure

FMED Industry Exposure


This page (NASDAQ:FMED) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners